desipramine has been researched along with 27-hydroxycholesterol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Band, MR; Hernandez, A; Kummerow, FA; Liu, ZL; Zhou, Q | 1 |
Dias, IH; Fell, S; Griffiths, HR; Lip, GY; Mistry, J; Polidori, MC; Reis, A; Spickett, CM | 1 |
2 other study(ies) available for desipramine and 27-hydroxycholesterol
Article | Year |
---|---|
27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells.
Topics: Analysis of Variance; Carbon Radioisotopes; Cells, Cultured; Desipramine; DNA Primers; Endothelial Cells; Gene Expression Regulation, Enzymologic; Glutathione; Humans; Hydroxycholesterols; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrophotometry; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2004 |
Oxidized LDL lipids increase β-amyloid production by SH-SY5Y cells through glutathione depletion and lipid raft formation.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line, Tumor; Cell Survival; Cholesterol, LDL; Desipramine; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; Glutathione Disulfide; Humans; Hydroxycholesterols; Lipid Metabolism; Lipoproteins, LDL; Membrane Microdomains; Oxidation-Reduction; Sphingomyelin Phosphodiesterase | 2014 |